DSIP - Research Peptide

Description

Components & Typical Quantities (custom blends may vary):

• DSIP: 10mg

• Total Peptide Content: 10mg lyophilized powder
  Form: Lyophilized Peptide
  Purity: ≥ 98% (HPLC Verified)

Product Overview:

• DSIP acts as a neuromodulator of the sleep-wake cycle and stress response. Administration consistently increases delta-wave (slow-wave) sleep in EEG recordings, suggesting it promotes the initiation and maintenance of deep, non-REM sleep. DSIP readily crosses the blood-brain barrier to exert central effects and may enhance inhibitory neuronal activity or modulate sleep-regulating brain regions. Additionally, DSIP attenuates ACTH and corticosterone release in response to stress, indicating an effect on the hypothalamic-pituitary-adrenal axis. Unlike conventional sedatives, DSIP tends to normalize sleep architecture without next-day grogginess.

Applications in Research:

• Observations from preclinical and clinical literature.

  • Supports improved sleep quality and increased slow-wave (delta) sleep duration.
  • May help normalize disrupted sleep patterns in chronic insomnia.
  • Shows potential for stress reduction and mood support through HPA axis modulation.
  • Remarkably safe profile: animal studies found no lethal dose even at extremely high doses; human studies report only mild, transient side effects (occasional headache or nausea).
  • Occasional mild injection-site reactions (redness/itch) may occur with subcutaneous administration.

Storage & Handling:

Store lyophilized powder at -20°C in a light- and moisture-free environment.
Reconstitute under sterile lab conditions with bacteriostatic water. Refrigerate after reconstitution and avoid multiple freeze-thaw cycles.

⚠️ Research Use Only – Legal Disclaimer

All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.

Biogenic Foods, LLC is a chemical supplier. Biogenic Foods is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Biogenic Foods is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.